Earnings Preview: Key Expectations for AstraZeneca, Nucor, Celestica
- July 25th, 2026
- 140 views
LAS VEGAS, NV / CRWE PRESS RELEASE / July 25, 2026 - Several companies are expected to unveil their financial results on Monday, July 27, including:
AstraZeneca PLC (NYSE: AZN), the global biopharmaceutical company known for its portfolio of oncology, cardiovascular, and rare disease treatments, will release its first-half and second quarter 2026 results before the stock market opens. Wall Street expects earnings per share (EPS) of $1.27 on revenue of $15.43 billion. $AZN closed at $169.26 on Friday, gaining $0.99 (0.59%).
Nucor Corporation (NYSE: NUE), one of North America's largest steel producers, plans to report its second quarter fiscal 2026 earnings after the markets close. The consensus estimate calls for EPS of $4.53 on revenue of $10.13 billion. $NUE ended Friday's session at $247.56, advancing $6.41 (2.66%).
Celestica Inc. (NYSE: CLS) (TSX: CLS), a provider of manufacturing, hardware platform, and supply chain solutions for technology customers, will release its second quarter 2026 financial results following the closing bell. Analysts anticipate EPS of $2.31 on revenue of $4.39 billion. $CLS closed at $305.28 on Friday, declining $29.47 (8.80%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
FDA Grants Accelerated Approval to a New Breast Cancer Treatment
September 04th, 2026Signing Day Is Not the End of Recruiting
September 04th, 2026Treasury, IRS Move to End Tax-Exempt Status for Discriminatory Practices in Private Schools
September 03rd, 2026FDA Approves First Drug to Treat Alexander Disease
September 03rd, 2026How Coaching Staffs Evaluate Athletes Across a Season
September 03rd, 2026




Member Login